Jove
Visualize
Contact Us

Related Experiment Videos

Community prostate cancer screening.

A Klamet1, F Crighton, R Deisher

  • 1Cancer Screening and Education Services for The Cancer Institute of Health Midwest, Kansas City, Missouri 64108, USA.

Cancer Practice
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

The Mission to Lepers in India and the East.

The Hospital·2018
Same author

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.

British journal of cancer·2010
Same author

Defining and measuring fatigue.

Image--the journal of nursing scholarship·1999
Same journal

Darbepoetin alfa: a review of its use in patients with cancer.

Cancer practice·2002
Same journal

Cancer genetics: information sources for patients and families.

Cancer practice·2002
Same journal

Bladder cancer: epidemiology, diagnosis, and management.

Cancer practice·2002
Same journal

Patient and caregiver interest in internet-based cancer services.

Cancer practice·2002
Same journal

Tapestry: a retreat program of support for persons living with cancer.

Cancer practice·2002
Same journal

Viatical settlements: effects on terminally ill patients.

Cancer practice·2002
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Community prostate cancer screening programs can overcome patient barriers to recommended screenings. This prototype details planning, staffing, promotion, finance, and follow-up for effective cancer prevention.

Area of Science:

  • Oncology
  • Public Health
  • Preventive Medicine

Background:

  • Health promotion and cancer prevention are crucial in cancer care.
  • Barriers often prevent patients from undergoing recommended cancer screenings.
  • Community-based programs offer a strategy to overcome these barriers.

Purpose of the Study:

  • To present a prototype for a community prostate cancer screening program.
  • To outline key components for successful program implementation.
  • To provide insights for future program development and improvement.

Main Methods:

  • Detailed explanation of program planning, staffing, and promotional strategies.
  • Description of cost, finance, and follow-up activities.
  • Inclusion of communication tools, follow-up protocols, and 4-year results.

Related Experiment Videos

Main Results:

  • The article describes the implementation and outcomes of a community prostate cancer screening program over four years.
  • Examples of communication tools and follow-up protocols are provided.
  • Data from four years of screening activities are presented.

Conclusions:

  • Community cancer screening programs are effective in addressing barriers to patient screening.
  • The presented prototype offers a framework for developing and improving such programs.
  • Recommendations are provided for enhancing future community screening initiatives.